OncoPanels with DNBSEQ
On Demand
1hr 59mins
Comprehensive genomic profiling is essential for precision oncology. The speakers evaluated cancer gene panels on MGI's G400 and G99 DNBSEQ systems. Agilent's assay offers tumor profiling on G400; GenePLUS has a 1021-gene panel; NGeneBio targets 18-343 genes for various cancers. These systems achieve >90% Q30, >50X coverage, detecting variants down to 1% allele frequency. MGI's systems offer speed, scalability, and cost-effectiveness, supporting both large and targeted panels for cancer research and diagnostics, advancing genomic medicine.
Dr. William Tan Associate Director @MiRXES
Dr. Michael Ruvolo Director, R&D @Agilent Technologies
Dr. Xiaorui Han Overseas Product Manager @Geneplus
Dr. Felicity Hall Senior Global Product Manager @Agilent Technologies
Dr. Kathy K.S. Lee Team leader @NGeneBio
Jun 6, 2023
1hr 6mins
Jun 13, 2023
1hr 21mins
Jun 20, 2023
1hr 27mins
Aug 16, 2023
1hr 19mins
Sep 20, 2023
55mins
Oct 26, 2023
1hr 58mins
Feb 1, 2024
1:04:45
Mar 6, 2024
43min
Apr 24, 2024
46.51
May 20, 2024